Braidwell's Karnal on How AI Can Impact Bioscience
Share
Alex Karnal, Co-Founder and CIO of Braidwell, joins Bloomberg's Anna Edwards on "The Pulse" to discuss the company's approach to investing in transformative medicines, technologies, and medical devices by integrating artificial intelligence.
More from Australia
American Tungsten completes Nexus acquisition for Pinnacle MOU
Butn extends MYOB invoice financing agreement to 2027
Celsius Resources updates market on US$5M dispute
Estrella Resources signs sales deal for 27,000 tonnes
McPherson's reports $20.3M full year net loss
Novatti reaches €1.2B quarterly transaction volume